Set as Homepage - Add to Favorites

日韩欧美成人一区二区三区免费-日韩欧美成人免费中文字幕-日韩欧美成人免费观看-日韩欧美成人免-日韩欧美不卡一区-日韩欧美爱情中文字幕在线

【teacher has sex with student video tristan】New therapy could help treat skin infections without turning them into superbugs

With concerns about the rise of so-called "superbugs" at an all-time high,teacher has sex with student video tristan scientists are on a mission to find better ways to tackle infections. And a new study, published last week in the journal PLOS ONE, claims to have done just that.

The research describes a new strategy that aims to tackle skin infections -- which can be particularly dangerous in hospital patients and the elderly -- without creating antibiotic-resistant bacteria in the process.

SEE ALSO: 3D-Printed Bacteria May Unlock Secrets of Disease

The treatment works by making it harder for bacteria to stick to human cells and therefore easier to wash away.


You May Also Like

Most importantly, the treatment has a low risk of contributing to the rise of antibiotic-resistant bacteria. And according to scientists, developing such treatments is critically important.

The "superbug" problem

Experts agree that antibiotic-resistant bacteria are a growing problem, and are largely the result of the excessive use of antibiotics in recent decades.

Antibiotics are generally designed to treat infections by killing bacteria en masse. The problem is that in any given colony of bacteria, a few individuals may have special genes that render them resistant to the antibiotics. So when the rest of the population dies off, these individuals remain and can pass on their genes, giving rise to whole strains of resistant bacteria.

Via Giphy

Often, such bacteria can still be treated with more aggressive drugs. But some types of antibiotic-resistant bacteria may be more challenging and sometimes not treatable at all, according to Paul Fey, a professor and Staph expert at the University of Nebraska Medical Center.

Just a few months ago, in fact, researchers announced the first caseof a patient in the U.S. carrying bacteria resistant to even the most aggressive "last-resort" antibiotics. The incident has sparked concern among health officials that the nation could eventually witness the rise of multi-drug resistant superbugs, impossible to treat with existing antibiotics.

A new therapy for skin infections

The new study focuses on a type of bacteria called Staphylococcus aureus, or "Staph" -- one of the leading causes of skin and wound infections. Staph can be especially dangerous in hospital patients, the elderly and other people whose immune systems may be compromised and less capable of tackling infections on their own.

A type of antibiotic-resistant Staph, commonly known as MRSA, is especially dangerous. The CDC estimatesthat more than 80,000 invasive MRSA infections occurred nationwide in 2011. MRSA infections are more difficult to treat than regular Staph infections, and when severe enough, they can move from the skin into the bloodstream and even become fatal.

Mashable Trend Report Decode what’s viral, what’s next, and what it all means. Sign up for Mashable’s weekly Trend Report newsletter. By clicking Sign Me Up, you confirm you are 16+ and agree to our Terms of Use and Privacy Policy. Thanks for signing up!

Staph bacteria use certain mechanisms to stick to human skin cells and launch infections. One way they do this is by interacting with special types of proteins in skin cells called "tetraspanins." These proteins are involved in all kinds of important cell functions, but they also have properties that make them “sticky” to foreign cells and molecules -- meaning bacteria can exploit them as a way to infect human cells.

"You can think of them as like a patch of velcro sticking out from the surface of the skin cells"

"You can think of them as like a patch of velcro sticking out from the surface of the skin cells," said Sheila MacNeil, a professor of tissue engineering at the University of Sheffield and one of the new study’s authors, in an interview with Mashable.

In the new study, the researchers synthetically created a series of peptides -- special molecules composed of a chain of amino acids -- that they hoped would make it more difficult for bacteria to cling to these spots.

The researchers tested their peptides on several types of skin cells in the laboratory, as well as a special 3D, lab-created human skin model to test the peptides on.

The researchers found that their peptides worked best in cells called keratinocytes -- the body’s outermost layer of skin cells and first line of defense against infections -- where they were able to reduce the bacterial burden by about 50 percent. They received similar results in their tests on the 3D skin model.

The researchers can’t yet say for sure exactly how the peptides are causing this effect, but they know the treatment somehow reduces the "stickiness" of the tetraspanins.

Importantly, the treatment worked on antibiotic-resistant Staph strains -- and it also showed no signs of killing the bacteria, meaning it has a low likelihood of contributing to the rise of new antibiotic-resistant strains. The treatment also didn’t seem to have any adverse effects on the human cells.

That said, this study suggests that the treatment only helps to remove about half the bacteria from skin cells. According to MacNeil, the researchers hope the therapy can reduce bacterial burdens just enough to make it easier for the patient’s immune system to start tackling the infection.

The future of antibiotics

To be clear, the new study only describes the method’s effects in a laboratory setting. But the researchers are planning to conduct additional tests over the next few years and hope the treatment can be tested in clinical trials (meaning with real humans) within three to five years.

If successful, the researchers hope the peptides could be placed in creams, gels or sprays that could then be applied to wounds. Such treatments would likely be most appropriate in high-risk populations, such as hospital patients or people undergoing surgery, said Fey, the University of Nebraska professor (who was not involved in the new study).

It's certainly not the only strategy that’s been explored when it comes to the fight against superbugs.

"There are a lot of pharmaceutical companies looking at vaccines against Staphylococcus aureus," Fey pointed out. And other studies have explored therapies aimed at boosting patients’ immune systems to help them tackle infections with less help from antibiotics.

The new research only adds to this arsenal of strategies.

"[In the future] I think there will be a lot of development of therapies that tackle bacteria that work alongside the patient’s immune system," MacNeil said. "We still need antibiotics, but we need to use them a lot less and only use them when we absolutely need."

0.1284s , 14261.640625 kb

Copyright © 2025 Powered by 【teacher has sex with student video tristan】New therapy could help treat skin infections without turning them into superbugs,Public Opinion Flash  

Sitemap

Top 主站蜘蛛池模板: 无码av天天av天天爽 | 国产午夜精品一本在线观看 | 日本午夜精品视频一区二区 | 在线成人免费观看国产精品 | 亚洲深夜福利在线观看免费 | 一区二区中文字幕人妻寝取 | 无码精品加勒比视频 | 人妻熟女成人免费视频 | 久久精品国产亚洲一区二区三区 | 欧美成人免费观看久久 | 99久久亚洲国产精品免费 | 国产日韩精品免费一二三区 | 久久精品免费人成人A片 | 强奷乱码欧妇女中文字幕熟女 | 手机看片久久久久久久久 | 国产精品无码av天天爽播放器 | 乱人伦人妻精品一区二区 | 亚洲成a人一区二区三区 | 精东视频影视传媒制作公司 | 久久久噜噜噜久久熟女av | 91国在线国内在线播放 | 欧美激情视频精品一 | 2024亚洲卡一卡二新区入口 | 一个人看的www片免费高清 | 久久国产露脸精品麻豆 | 日日摸夜夜添夜夜添A片公司 | 国产成人v大片在线观 | 日韩国产欧美亚洲v片 | 日本高清h色视频在线观看 日本高清VA在线播放 | 亚洲国产精品一区二区第一页免 | 亚洲精品一区二区三区新线路 | 成人综合伊人五月婷久久 | 久热精品在线视频 | 亚洲精品无码专区在线观看 | 国产片av国语在线观看手机版 | 精品女同一区二区三区免费播 | 国产成人综合欧美 | av无码特黄一级 | 人妻小说欧美中文字幕亚洲乱码熟女 | 国产高级桑拿会所在线看 | 国产精品精品推荐第一页 |